IRF5 and synovial sarcoma: Taken together, these findings suggest a possible association between the IRF5 gene variants and the induction of type I IFNs (through the induction of the IRF5 gene expression after a viral infection) that could lead to the robust activation of the immune system in salivary glands (target organ) as an early event in SS pathogenesis.